Philip Tsai Immunome Inc. (IMNM) insider trading activity
Philip Tsai is Chief Technology Officer of Immunome Inc.. Currently has a direct ownership of 21,000 shares of IMNM, which is worth approximately $283,920. The most recent transaction as insider was on Nov 21, 2024, when has been sold 21,000 shares (Common Stock) at a price of $9.43 per share, resulting in proceeds of $198,030. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
21K
n/a
3M change
n/a
12M change
Total Value Held
$283,920
PT
Philip Tsai
Chief Technology Officer
Bothell, WA